BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin J, Lin ZQ, Zheng SC, Chen Y. Immune checkpoint inhibitor-associated gastritis: Patterns and management. World J Gastroenterol 2024; 30(14): 1941-1948 [PMID: 38681126 DOI: 10.3748/wjg.v30.i14.1941]
URL: https://www.wjgnet.com/1007-9327/full/v30/i14/1941.htm
Number Citing Articles
1
Ying-Fang Deng, Xian-Shu Cui, Liang Wang. Reconceptualization of immune checkpoint inhibitor-associated gastritis. World Journal of Gastroenterology 2024; 30(36): 4031-4035 doi: 10.3748/wjg.v30.i36.4031
2
Nozomi Sano, Atsushi Naganuma, Kenta Ido, Hiroaki Naruse, Yuhei Suzuki, Tomoyuki Masuda, Takashi Hoshino, Hidetoshi Yasuoka, Toshio Uraoka, Satoru Kakizaki. Cytomegalovirus gastritis following immune checkpoint inhibitor-associated gastritis induced by ipilimumab and nivolumab therapy in a patient with renal cell carcinoma. Clinical Journal of Gastroenterology 2026; 19(2) doi: 10.1007/s12328-026-02290-8
3
Carolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, Krishnavathana Varatharajalu, Anusha Thomas, Yinghong Wang. Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management. Immunotherapy 2025; 17(4) doi: 10.1080/1750743X.2025.2473305
4
Jin Wook Lee. Immune Checkpoint Inhibitor-Induced Gastritis Mimicking Early Gastric Cancer. The Korean Journal of Gastroenterology 2026; 86(3) doi: 10.4166/kjg.2026.065
5
Justine Vivier Chicoteau, Lucie Thibault, Pauline Vaflard, Pauline Du Rusquec, Romain Seban, Catherine Daniel, Pascale Mariani, Delphine Loirat, Bruno Buecher. Toxicité digestive « supérieure » de l’immunothérapie. Bulletin du Cancer 2026; 113(2) doi: 10.1016/j.bulcan.2025.09.002
6
Grigorios Petrousis, Sylwester Szczegielniak, Haider Sabhan, Peter Elbe, Gülden Bilican, Hans Strid, Francesca Bresso, Charlotte Hedin, Stephan L Haas. Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review. World Journal of Gastrointestinal Endoscopy 2025; 17(7): 107798 doi: 10.4253/wjge.v17.i7.107798
7
Li-Li Yu, Zhi-Lin He, Xin-Lai Qian. Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies. World Journal of Gastroenterology 2024; 30(24): 3120-3122 doi: 10.3748/wjg.v30.i24.3120
8
Bo-Tong Ma, Li-Xuan Sang, Bing Chang. Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis. World Journal of Gastroenterology 2024; 30(24): 3123-3125 doi: 10.3748/wjg.v30.i24.3123
9
Tal Etan, Iddo Bar-Yishay, Ariel Greenberg, Eli Brazowsky, Miriam R Brezis, Shlomit Strulov Shachar, Mor Miodovnik, Ido Wolf, Yasmin Leshem. Rare occurrence of immunotherapy-related gastritis and duodenitis in a single tertiary medical center: a diagnostic challenge. The Oncologist 2025; 30(11) doi: 10.1093/oncolo/oyaf349
10
Lei Shi, Zhongqiao Lin, Huishan Zhang, Yuping Lu, Zequn Sun, Bin Lan, Huang Xia, Shuimei Luo, Ling Chen, Zhida Wu, Yuyang Huang, Mengru Quan, Xuefeng Wang, Jing Lin, Yu Chen. Spatial proteomics reveals four-stage molecular evolution in cancer immunotherapy-related gastritis. Molecular Cancer 2026; 25(1) doi: 10.1186/s12943-026-02737-z
11
Federico Sottotetti, Giovanni Arpa, Lucrezia Spina, Andrea Premoli, Katerina Vjero, Laura Deborah Locati, Marco Vincenzo Lenti. Severe cytomegalovirus gastritis and hypogammaglobulinemia in a patient treated with pembrolizumab. European Journal of Gastroenterology & Hepatology 2026; 38(9) doi: 10.1097/MEG.0000000000003231
12
Wenqiang Tang, Yun Lv, Xiyue Yang, Kunyuan Gan, Gang Feng, Jie Li, Lu Ni, Yuxi Bai, Xiaobo Du, Feng Gao. Sintilimab‑induced acute erosive hemorrhagic gastritis as an adverse reaction of third‑line therapy in a nasopharyngeal carcinoma patient: A case report. Oncology Letters 2025; 30(1) doi: 10.3892/ol.2025.15072
13
Tian Xu, Xueping Yang, Xinyu Chen, Qilin Wang, Juncai Ye, Chuanyu You, Jiao Zhu, Yan Gui. Emerging photothermal agents combined with immunotherapy for cancer treatment. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03669-8